102 results
PRE 14A
SYRS
Syros Pharmaceuticals Inc.
12 Apr 24
Preliminary proxy
4:30pm
;
the purpose of, and the potential benefits to us of, the transaction; and
any other information regarding the related person transaction or the related … of service as a non-employee director, and (iii) for Dr. Olson, $382,200 of severance benefits received in 2023, as described below under “ —Employment
8-K
EX-1.1
oqkrwq8k h6oiq0mo
19 Dec 23
Syros Announces Pricing of $45.0 million Underwritten Offering of Common Stock and Pre-Funded Warrants
4:59pm
424B5
9osfg4ea1u0qxg
19 Dec 23
Prospectus supplement for primary offering
4:53pm
424B5
bc3ou81x
1 May 23
Prospectus supplement for primary offering
4:06pm